Interactive Ultrasound Examination (4D ultrasound)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03424642 |
|
Recruitment Status :
Recruiting
First Posted : February 7, 2018
Last Update Posted : October 27, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Prenatal Anxiety | Behavioral: Interactive 4D-ultrasound examination | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 120 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Interactive Ultrasound Examination as Psychological Support for Pregnant Women |
| Actual Study Start Date : | January 1, 2018 |
| Estimated Primary Completion Date : | April 1, 2022 |
| Estimated Study Completion Date : | April 1, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Interactive 4D-ultrasound examination
Pregnant women who are randomized to 4D-ultrasound intervention group will receive additional 4D-ultrasound examinations 2-3 times between gestational weeks 25-32. Patients in this group will also receive psychologist's interview twice and fill out questionaries.
|
Behavioral: Interactive 4D-ultrasound examination
Randomized controlled trial |
|
No Intervention: Control group
Pregnant women who are randomized to control group will receive psychologist's interview twice twice and fill out questionaires.
|
- prenatal depressive symptoms [ Time Frame: Gestational weeks 21-24 ]EPDS (Edinburgh Pre/Postnatal depression scale). 10 questions, scale 0-30 points, cut of for major depression is 15 points.
- postnatal depressive symptoms [ Time Frame: 4 months postpartum ]EPDS (Edinburgh Pre/Postnatal Depression Scale) 0-30 points, cut-off for major depression is 15 points.
- general anxiety [ Time Frame: At gestational week 25 and at gestational week 32-33. ]SCL-90 (Symptom Checklist) measures general anxiety. Consists of 90 questions, each question contains 4 items. Higher score correlates positively with anxiety symptoms.
- pregnancy related anxiety [ Time Frame: At gestational week 25 and at gestational week 32-33 ]PRAQ-R2 (Pregnancy Related Anxiety Questionaire Revised) Measures pregnancy related anxiety. Consists of 11 questions, each containing 5 items. Higher score correlates positively with pregnancy related anxiety.
- maternal-fetal relations [ Time Frame: At gestational week 25 and 32-33 ]WMCI (Working Model of the Child Interview) is psychologists interview, that is a one-hour, semi-structured, exploring systematically the narrative patterns of parents' thoughts, feelings, and perceptions of their unborn baby and their emerging relationship. The scoring of the quality of parents' representations will be conducted from video recorded interviews. The quality and the content of the representations will be scored straight from the videotapes of the interviews using with the seven scales presented in the manual. The qualitative scales are richness of perceptions, openness to change, intensity of involvement, coherence, caregiving sensitivity, and acceptance. The content scales are infant difficulties and fear for the infant's safety. These scales will be scored with a Likert type scale ranging from 1 to 5. The parental representations will be classified based on the manual into three categories: balanced, disengaged, and distorted.
- maternal-fetal attachment [ Time Frame: At gestational week 25 and 32-33. ]MAAS (Maternal Antenatal Attachment Scale) is 19 questions containing questionaire. which focus on feelings, attitudes and behaviours towards the fetus with responses recorded on a 5 point Likert Scale. Maximum score is 95 points. High score correlates to strong attachment, low score to weak attachment.
- maternal-fetal attachment [ Time Frame: 4 months postpartum. ]MPAS (Maternal Postnatal Attachment Scale) is 19 questions containing questionaire. which focus on feelings, attitudes and behaviours towards the foetus with responses recorded on a 5 point Likert Scale. Maximum score is 95 points. High score correlates to strong attachment, low score to weak attachment.
- maternal-fetal fetal relations [ Time Frame: 4 months postpartum. ]
Parent Child Early Relational Assessment (PCERA) observation. Videotaped interplay is analysed by psychologist.
the foetus with responses recorded on a 5 point Likert Scale. Maximum score is 95 points. High score correlates to strong attachment, low score to weak attachment.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | pregnant women |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- pilot study(pregnant women who are hospitalized because of risk to preterm birth): singleton pregnancy, fluent in Finnish, age over 18
- randomized trial: EPDS 10-14 points, singleton pregnancy, fluent in Finnish, age over 18, BMI under 35
Exclusion Criteria:
- severe psychic symptoms e.g. suicidality, psychotic symptoms
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03424642
| Contact: Henrika P Pulliainen, md | +358445274024 | hpherm@utu.fi |
| Finland | |
| TYKS Naistenklinikka | Recruiting |
| Turku, Finland, 20521 | |
| Contact: Eeva K Ekholm, md eeva.ekholm@tyks.fi | |
| Principal Investigator: | Eeva MK Ekholm, ph d | TYKS |
| Responsible Party: | Turku University Hospital |
| ClinicalTrials.gov Identifier: | NCT03424642 |
| Other Study ID Numbers: |
150613090915 |
| First Posted: | February 7, 2018 Key Record Dates |
| Last Update Posted: | October 27, 2020 |
| Last Verified: | October 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
prenatal depression prenatal anxiety prenatal mental disorders interactive ultrasound examination maternal-fetal relations |

